3:00pm The Implications of a Biological Definition of Parkinson’s Disease on Preclinical Research
Time: 3:00 pm
day: Pre-Conference Day
Details:
Attend this practical, solution-focused workshop to:
- Examine the impact of biological definitions of Parkinson's disease on clinical trial design.
- Investigate the role of emerging biomarkers in the early detection, monitoring of disease progression, and assessment of therapeutic efficacy in Parkinson’s disease.
- Discuss how evolving clinical trial designs and emerging biomarkers will redefine evaluation of efficacy and target engagement in preclinical models.
